
#99 Bleeding vs. Clotting Risk: Gray Matters Segment
Core IM | Internal Medicine Podcast
Cancer Die
The longer I treat this patient's PE the less likely it is to recur with stopping anticoagulation. The number of sides of my dad goes up and it becomes maybe a one in 20 chance or a one in 50 chance that the PE progresses. We're rolling another dice by delaying the biopsy which can go from curable to incurable. And not only that but I actually don't even know which cancer die I'm rolling which would change the number of sides and how quickly they change. So what happened next? He started him on a pixivan and we planned to have him on the a p Pixivan for one month and then hold it for three days prior to
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.